Drug metabolism in microorganisms

Biotechnology Letters

Volumn 37, Issue 1, 2015, Pages 19-28

  Murphy, Cormac D ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Bacillus megaterium; Cunninghamella; Cytochrome P450; Metabolism; Streptomyces

Indexed keywords

BACTERIA; BACTERIOLOGY; BIOMOLECULES; ESCHERICHIA COLI; GENE ENCODING; METABOLISM; METABOLITES; MICROBIOLOGY; PHYSIOLOGY;

BACILLUS MEGATERIUM; CUNNINGHAMELLA; CYTOCHROME P450; DRUG METABOLISMS; HUMAN METABOLITES; MUTAGENESIS EXPERIMENT; RECOMBINANT MICROORGANISM; STREPTOMYCES;

MICROORGANISMS;

BACILLUS MEGATERIUM; BACTERIA (MICROORGANISMS); CUNNINGHAMELLA; FUNGI; STREPTOMYCES;

CYTOCHROME P450; DRUG;

BACTERIUM; BIOLOGICAL MODEL; BIOTRANSFORMATION; DRUG DEVELOPMENT; MEDICAL RESEARCH; METABOLISM;

BACTERIA; BIOMEDICAL RESEARCH; BIOTRANSFORMATION; CYTOCHROME P-450 ENZYME SYSTEM; DRUG DISCOVERY; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS;

EID: 84921716406     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-014-1653-8     Document Type: Review

References (48)

1. Amadio J, Gordon K, Murphy CD (2010) Biotransformation of flurbiprofen by Cunninghamella species. Appl Environ Microbiol 76:6299–6303
2. Amadio J, Casey E, Murphy CD (2013) Filamentous fungal biofilm for production of human drug metabolites. Appl Microbiol Biotechnol 97:5955–5963
3. Asha S, Vidyavathi M (2009) Cunninghamella—a microbial model for drug metabolism studies—a review. Biotechnol Adv 27:16–29
4. Bright TV, Clark BR, O’Brien E, Murphy CD (2011) Bacterial production of hydroxylated and amidated metabolites of flurbiprofen. J Mol Catal B 72:116–121
5. Bright TV, Dalton F, Elder VL, Murphy CD, O’Connor NK, Sandford G (2013) A convenient chemical–microbial method for developing fluorinated pharmaceuticals. Org Biomol Chem 11:1135–1142
6. Buchheit D, Dragan CA, Schmitt EI, Bureik M (2011) Production of ibuprofen acyl glucosides by human UGT2B7. Drug Metab Dispos 39:2174–2181
7. Cerniglia CE, Yang SK (1984) Stereoselective metabolism of anthracene and phenanthrene by the fungus Cunninghamellaelegans. Appl Environ Microbiol 47:119–124
8. Cornelissen S, Julsing MK, Schmid A, Bühler B (2012) Comparison of microbial hosts and expression systems for mammalian CYP1A1 catalysis. J Ind Microbiol Biotechnol 39:275–287
9. Di Nardo G, Fantuzzi A, Sideri A, Panicco P, Sassone C, Giunta C, Gilardi G (2007) Wild-type CYP102A1 as a biocatalyst: turnover of drugs usually metabolised by human liver enzymes. J Biol Inorg Chem 12:313–323
10. Drăgan CA, Peters FT, Bour P, Schwaninger AE, Schaan SM, Neunzig I, Widjaja M, Zapp J, Kraemer T, Maurer HH, Bureik M (2011) Convenient gram-scale metabolite synthesis by engineered fission yeast strains expressing functional human P450 systems. Appl Biochem Biotechnol 163:965–980
11. Ferris JP, Macdonald LH, Patrie MA, Martin MA (1976) Aryl-hydrocarbon hydroxylase-activity in fungus Cunninghamellabainieri—evidence for presence of cytochrome-P-450. Arch Biochem Biophys 175:443–452
12. Geier M, Braun A, Emmerstorfer A, Pichler H, Glieder A (2012) Production of human cytochrome P450 2D6 drug metabolites with recombinant microbes—a comparative study. Biotechnol J 7:1346–1358
13. Gonzalez FJ, Korzekwa KR (1995) Cytochromes P450 expression systems. Ann Rev Pharmacol Toxicol 35:369–390
14. Han CH, Barrios FJ, Riofski MV, Colby DA (2009) Semisynthetic Derivatives of Sesquiterpene lactones by palladium-catalyzed arylation of the alpha-methylene-gamma-lactone substructure. J Org Chem 74:7176–7179
15. Jezequel SG (1998) Microbial models of mammalian metabolism: uses and misuses (clarification of some misconceptions). J Mol Catal B 5:371–377
16. Kolev JN, Zaengle JM, Ravikumar R, Fasan R (2014) Enhancing the efficiency and regioselectivity of P450 oxidation catalysts by unnatural amino acid mutagenesis. ChemBioChem 15:1001–1010
17. Lamb DC, Skaug T, Song HL, Jackson CJ, Podust LM, Waterman MR, Kell DB, Kelly DE, Kelly SL (2002) The cytochrome p450 complement (CYPome) of Streptomyces coelicolor A3(2). J Biol Chem 277:24000–24005
18. Lamb DC, Waterman MR, Zhao B (2013) Streptomyces cytochromes P450: applications in drug metabolism. Expert Opin Drug Metab Toxicol 9:1279–1294
19. Li HY, Poulos TL (1997) The structure of the cytochrome P450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid. Nat Struct Biol 4:140–146
20. Lin LH, Huang HH, Zhang P, Qi XL, Zhong DF (2007) Microbial transformation of dextromethorphan by Cunninghamellablakesleeana AS 3.153. Chem Pharm Bull 55:658–661
21. Lisowska K, Szemraj J, Rozalska S, Dlugonski J (2006) The expression of cytochrome P-450 and cytochrome P-450 reductase genes in the simultaneous transformation of corticosteroids and phenanthrene by Cunninghamellaelegans. FEMS Microbiol Lett 261:175–180
22. Martina G, Christian S, Anton G (2013) First functional expression of cytochrome P450 3A4 in Pichia pastoris. Chim Oggi-Chem Today 31:24–27
23. Narhi LO, Fulco AJ (1986) Characterization of a catalytically self-sufficient 119,000-dalton cytochrome P-450 monooxygenase induced by barbiturates in Bacillusmegaterium. J Biol Chem 261:7160–7169
24. Noble MA, Miles CS, Chapman SK, Lysek DA, Mackay AC, Reid GA, Hanzlik RP, Munro AW (1999) Roles of key active-site residues in flavocytochrome P450 BM3. Biochem J 339:371–379
25. Omiecinski CJ, Remmel RP, Hosagrahara VP (1999) Concise review of the cytochrome P450s and their roles in toxicology. Toxicol Sci 48:151–156
26. Osorio-Lozada A, Surapaneni S, Skiles GL, Subramanian R (2008) Biosynthesis of drug metabolites using microbes in hollow fiber cartridge reactors: case study of diclofenac metabolism by Actinoplanes species. Drug Metab Dispos 36:234–240
27. Paludo CR, da Silva EA, Santos RA, Pupo MT, Emery FS, Furtado N (2013) Microbial transformation of beta-lapachone to its glycosides by Cunninghamellaelegans ATCC 10028b. Phytochem Lett 6:657–661
28. Peters FT, Drăgan C-A, Wilde DR, Meyer MR, Zapp J, Bureik M, Maurer HH (2007) Biotechnological synthesis of drug metabolites using human cytochrome P450 2D6 heterologously expressed in fission yeast exemplified for the designer drug metabolite 4′-hydroxymethyl-alpha-pyrrolidinobutyrophenone. Biochem Pharmacol 74:511–520
29. Peters FT, Drăgan C-A, Kauffels A, Schwaninger AE, Zapp J, Bureik M, Maurer HH (2009a) Biotechnological synthesis of the designer drug metabolite 4′-hydroxymethyl-alpha-pyrrolidinohexanophenone in fission yeast heterologously expressing human cytochrome P450 2D6—a versatile alternative to multistep chemical synthesis. J Anal Toxicol 33:190–197
30. Peters FT, Drăgan C-A, Schwaninger AE, Sauer C, Zapp J, Bureik M, Maurer HH (2009b) Use of fission yeast heterologously expressing human cytochrome P450 2B6 in biotechnological synthesis of the designer drug metabolite N-(1-phenylcyclohexyl)-2-hydroxyethanamine. Forensic Sci Int 184:69–73
31. Pothuluri JV, Selby A, Evans FE, Freeman JP, Cerniglia CE (1995) Transformation of chrysene and other polycyclic aromatic hydrocarbon mixtures by the fungus Cunninghamellaelegans. Can J Bot 73:S1025–S1033
32. Prior JE, Shokati T, Christians U, Gill RT (2010) Identification and characterization of a bacterial cytochrome P450 for the metabolism of diclofenac. Appl Microbiol Biotechnol 85:625–633
33. Reinen J, van Leeuwen JS, Li YM, Sun LF, Grootenhuis PDJ, Decker CJ, Saunders J, Vermeulen NPE, Commandeur JNM (2011) Efficient screening of cytochrome P450 BM3 mutants for their metabolic activity and diversity toward a wide set of drug-like molecules in chemical space. Drug Metab Dispos 39:1568–1576
34. Rentmeister A, Arnold FH, Fasan R (2009) Chemo-enzymatic fluorination of unactivated organic compounds. Nat Chem Biol 5:26–28
35. Rydevik A, Bondesson U, Thevis M, Hedeland M (2013a) Mass spectrometric characterization of glucuronides formed by a new concept, combining Cunninghamellaelegans with TEMPO. J Pharm Biomed Anal 84:278–284
36. Rydevik A, Thevis M, Krug O, Bondesson U, Hedeland M (2013b) The fungus Cunninghamellaelegans can produce human and equine metabolites of selective androgen receptor modulators (SARMs). Xenobiotica 43:409–420
37. Sariaslani FS, Kunz DA (1986) Induction of cytochrome-p-450 in Streptomyces griseus by soybean flour. Biochem Biophys Res Commun 141:405–410
38. Sariaslani FS, Rosazza JP (1983) Novel biotransformations of 7-ethoxycoumarin by Streptomyces griseus. Appl Environ Microbiol 46:468–474
39. Sawayama AM, Chen MMY, Kulanthaivel P, Kuo MS, Hemmerle H, Arnold FH (2009) A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds. Chem Eur J 15:11723–11729
40. Smith RV, Rosazza JP (1974) Microbial models of mammalian metabolism—aromatic hydroxylation. Arch Biochem Biophys 161:551–558
41. Taylor M, Lamb DC, Cannell R, Dawson M, Kelly SL (1999) Cytochrome P450105D1 (CYP105D1) from Streptomyces griseus: heterologous expression, activity, and activation effects of multiple xenobiotics. Biochem Biophys Res Commun 263:838–842
42. Tracy TS, Rosenbluth BW, Wrighton SA, Gonzalez FJ, Korzekwa KR (1995) Role of cytochrome P450 2C9 and an allelic variant in the 4′-hydroxylation of (R)-flurbiprofen and (S)-flurbiprofen. Biochem Pharmacol 49:1269–1275
43. Tracy TS, Marra C, Wrighton SA, Gonzalez FJ, Korzekwa KR (1996) Studies of flurbiprofen 4′-hydroxylation—additional evidence suggesting the sole involvement of cytochrome P450 2C9. Biochem Pharmacol 52:1305–1309
44. Trower MK, Sariaslani FS, O’Keefe DP (1989) Purification and characterization of a soybean flour-induced cytochrome P450 from Streptomyces griseus. J Bacteriol 171:1781–1787
45. Tsotsou GE, Sideri A, Goyal A, Di Nardo G, Gilardi G (2012) Identification of mutant Asp251Gly/Gln307His of cytochrome P450 BM3 for the generation of metabolites of diclofenac, ibuprofen and tolbutamide. Chem Eur J 18:3582–3588
46. Vail R, Homann M, Hanna I, Zaks A (2005) Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed in Escherichia coli. J Ind Microbiol Biotechnol 32:67–74
47. Wang RF, Cao WW, Khan AA, Cerniglia CE (2000) Cloning, sequencing, and expression in Escherichia coli of a cytochrome P450 gene from Cunninghamellaelegans. FEMS Microbiol Lett 188:55–61
48. Zhang DL, Yang YF, Leakey JEA, Cerniglia CE (1996) Phase I and phase II enzymes produced by Cunninghamellaelegans for the metabolism of xenobiotics. FEMS Microbiol Lett 138:221–226